Third, some trials disclose ends in publications or conferences with no entirely updating registry fields, whereas other trials may very well be registered but never progress to enrollment, introducing uncertainty when using registration as a proxy for Lively growth. Fourth, our rule-primarily based harmonization for subtype and concentrate on clas